Yayın:
Prolonged survival of a case with three different malignancies - cutaneous malignant melanoma, gastrointestinal stromal tumor and thyroid papillary cancer: A case report

dc.contributor.authorBukun, Hulya Odabasi
dc.contributor.authorCubukcu, Erdem
dc.contributor.authorSahin, Ahmet Bilgehan
dc.contributor.authorAdim, Saduman Balaban
dc.contributor.buuauthorODABAŞI BÜKÜN, HÜLYA
dc.contributor.buuauthorÇUBUKÇU, ERDEM
dc.contributor.buuauthorŞAHİN, AHMET BİLGEHAN
dc.contributor.buuauthorBALABAN ADIM, ŞADUMAN
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.orcid0009-0000-5432-4981
dc.contributor.orcid0000-0002-7846-0870
dc.contributor.researcheridAAM-4927-2020
dc.contributor.researcheridJPX-6130-2023
dc.contributor.researcheridETP-1691-2022
dc.contributor.researcheridEMN-0789-2022
dc.date.accessioned2025-10-21T08:51:26Z
dc.date.issued2025-09-01
dc.description.abstractThis case report presents an extraordinary instance of a patient diagnosed with three separate primary malignancies: gastrointestinal stromal tumor (GIST), papillary thyroid carcinoma (PTC) and cutaneous malignant melanoma. The occurrence of such a combination of multiple primary cancers in a single individual is exceptionally rare, and to our knowledge, has not been previously documented in the medical literature. The patient underwent a comprehensive treatment regimen, including surgery and adjuvant imatinib for GIST, thyroidectomy, radioactive iodine therapy for PTC, as well as a combination of systemic and local treatments for metastatic malignant melanoma. Of note, the patient achieved a significantly prolonged survival, particularly in the context of metastatic melanoma, which is generally associated with a poor prognosis. This case underscores the effectiveness of a multidisciplinary and targeted treatment approach in managing complex cases involving multiple malignancies. It also emphasizes the potential benefits of integrating various oncological therapies, including tyrosine kinase inhibitors and immunotherapy, to achieve favorable outcomes in patients with multiple primary cancers.
dc.identifier.doi10.3892/ol.2025.15185
dc.identifier.issn1792-1074
dc.identifier.issue3
dc.identifier.scopus2-s2.0-105011170122
dc.identifier.urihttps://doi.org/10.3892/ol.2025.15185
dc.identifier.urihttps://hdl.handle.net/11452/55745
dc.identifier.volume30
dc.identifier.wos001540022600001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherSpandidos Publications
dc.relation.journalOncology Letters
dc.subjectKit
dc.subjectImatinib
dc.subjectMultiple primary malignancies
dc.subjectGastrointestinal stromal tumor
dc.subjectThyroid papillary carcinoma
dc.subjectMalignant melanoma
dc.subjectTargeted therapy
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectOncology
dc.titleProlonged survival of a case with three different malignancies - cutaneous malignant melanoma, gastrointestinal stromal tumor and thyroid papillary cancer: A case report
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublication412d71e5-b252-44f8-adee-b25da4e5dca6
relation.isAuthorOfPublicationf971677f-09c5-4463-bf01-3c6341fbe5f7
relation.isAuthorOfPublication4dc703eb-05b2-4b24-b6ad-dcaca00b36d9
relation.isAuthorOfPublication80df1863-762d-4cc1-9313-2d77d9e79ff8
relation.isAuthorOfPublication.latestForDiscovery412d71e5-b252-44f8-adee-b25da4e5dca6

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Bukun_vd_2025.pdf
Boyut:
2.91 MB
Format:
Adobe Portable Document Format